Sharekhan

Epigral Ltd

Wed 21/05/2025,15:51:44 NSE: EPIGRAL

₹ 1886.00 -2.30 (-0.12%)
BUY NOW Buy Epigral Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Epigral Ltd

Wed 21/05/2025,16:1:0

Epigral Ltd

Wed 21/05/2025,15:51:44 | NSE : EPIGRAL

₹ 1886.00-2.30 (-0.12%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1900.00

Previous Close

₹ 1888.30

Volume

35300

Mkt Cap ( Rs. Cr)

₹8136.46

High

₹ 1937.70

Low

₹ 1870.10

52 Week High

₹ 2406.75

52 Week Low

₹ 1110.05

Book Value Per Share

₹ 324.94

Dividend Yield

0.31

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Epigral Ltd

Your Vote -

Buy

53.13%

Hold

42.71%

Sell

4.17%

53.13%

96 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

1886.00

20

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

20

Option Chain

Analyzes market sentiment, predicts Epigral Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    20 May 2025, 6:34PM The Management of the Company is participating in the 4th MACM Invest India Global Conference on 22.05.2025.

  • Epigral Ltd - Shareholders meeting

    16 May 2025, 5:03PM Epigral Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot

  • Epigral Ltd - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    16 May 2025, 5:02PM Postal Ballot Scrutinizer's Report.

  • Epigral Ltd - Analysts/Institutional Investor Meet/Con. Call Updates

    8 May 2025, 4:21PM Epigral Limited has informed the Exchange about Transcript

  • Epigral Ltd - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    8 May 2025, 4:26PM Epigral Limited submits transcript of conference call held on 05.05.2025 discussing Q4 & FY 2025 - results.

  • Epigral Ltd - Copy of Newspaper Publication

    6 May 2025, 4:45PM Epigral Limited has informed the Exchange about Copy of Newspaper Publication

  • Epigral Ltd - Statement Of Deviation Or Variation In Utilization Of The Funds Raised Through The Qualified Institutions Place

    5 May 2025, 11:00PM Epigral Limited submits statement of deviation or variation of utilization of the funds raised through the Qualified Institutions Placement (QIP) for

  • Epigral Ltd - Statement of deviation(s) or variation(s) under Reg. 32

    5 May 2025, 10:49PM Epigral Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32

  • Epigral Ltd - Outcome of Board Meeting-XBRL

    5 May 2025, 10:45PM EPIGRAL LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 05-May-2025 for Dividend

  • Epigral Ltd - Analysts/Institutional Investor Meet/Con. Call Updates

    5 May 2025, 10:44PM Epigral Limited has informed the Exchange about Link of Recording

  • Epigral Ltd - Monitoring Agency Report

    5 May 2025, 10:43PM Monitoring Agency Report for the quarter ended 31st March, 2025

  • Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    5 May 2025, 10:38PM Audio Recording of Conference Call discussing Q4 & FY25 Results.

  • Epigral Ltd - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    5 May 2025, 10:33PM MONITORING AGENCY REPORT FOR THE QUARTER ENDED ON 31.03.2025.

  • Epigral Ltd - Corporate Action-Board approves Dividend

    5 May 2025, 9:22PM The Board of Directors at its Meeting held today i.e. 5th May, 2025, recommended final dividend of Rs. 3.5 (35%) per equity share of Rs. 10/- each for

  • Epigral Ltd - Press Release

    5 May 2025, 3:14PM Epigral Limited has informed the Exchange regarding a press release dated May 05, 2025, titled ""Press Release for Audited Financial Results Q4 & FY

  • Epigral Ltd - Investor Presentation

    5 May 2025, 3:08PM Epigral Limited has informed the Exchange about Investor Presentation

  • Epigral Ltd - Dividend

    5 May 2025, 3:06PM Epigral Limited has informed the Exchange that Board of Directors at its meeting held on May 05, 2025, recommended Final Dividend of 3.5 per equity sh

  • Epigral Ltd - Outcome of Board Meeting

    5 May 2025, 2:57PM Epigral Limited has informed the Exchange regarding Outcome of Board Meeting held on May 05, 2025.

  • Epigral Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    5 May 2025, 3:12PM Press Release for Audited Financial Results Q4 & FY2025.

  • Epigral Ltd - Announcement under Regulation 30 (LODR)-Investor Presentation

    5 May 2025, 3:10PM Investor Presentation for Audited Financial Results - Q4 & FY 2025.\r\n

  • Epigral Ltd - Board Meeting Outcome for Outcome Of Board Meeting Held On Monday, 5Th May, 2025 And Submission Of Audited Fina

    5 May 2025, 3:04PM Outcome of Board Meeting held on Monday, 5th May, 2025 and submission of Audited Financial Results (Standalone & Consolidated) for the Fourth Quarter

  • Epigral Ltd - FINANCIAL RESULTS - Q4 AND FY 2025.

    5 May 2025, 3:02PM AUDITED FINANCIAL RESULTS - Q4 & FY 2025.

  • Epigral Ltd Q4 net profit up 12.98% at Rs 86.62 cr

    5 May 2025, 3:00PM The company reported standalone net profit of Rs 86.62 crore for the quarter ended March 31, 2025 as compared to Rs 76.67 crore in the same period las

  • Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    29 Apr 2025, 7:26PM Epigral Limited has informed the Exchange about Conference Call on Monday, 5th May, 2025 to discuss Q4 FY25 Results

  • Epigral Ltd - Analysts/Institutional Investor Meet/Con. Call Updates

    29 Apr 2025, 7:23PM Epigral Limited has informed the Exchange about Conference Call on Monday, 5th May, 2025 to discuss Q4 FY25 Results

  • Epigral Ltd - Board Meeting Intimation

    23 Apr 2025, 12:11PM EPIGRAL LIMITED has informed the Exchange about Board Meeting to be held on 05-May-2025 to consider and approve the Yearly Audited Financial results o

  • Epigral Ltd - Board Meeting Intimation for Consideration & Approval Of Audited Financial Results And Recommendation Of Final

    23 Apr 2025, 12:13PM Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2025 ,inter alia, to consider and approve

  • Epigral Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    16 Apr 2025, 7:41PM As of March 2025, 68.95% is owned by Indian Promoters and 31.05% by Public. <p align=justify> Top five Promoters holding highest number of shares of E

  • Epigral Ltd - Copy of Newspaper Publication

    16 Apr 2025, 6:24PM Epigral Limited has informed the Exchange about Newspaper Publication Notice of Postal Ballot

  • Epigral Ltd - Shareholders meeting

    15 Apr 2025, 12:28PM Epigral Limited has informed the Exchange regarding Notice of Postal Ballot

  • Epigral Ltd - Notice Of Shareholders Meetings-XBRL

    15 Apr 2025, 12:19PM EPIGRAL LIMITED has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot

  • Epigral Ltd - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    15 Apr 2025, 12:26PM Postal Ballot Notice dated 12.04.2025.

  • Epigral Ltd - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    5 Apr 2025, 1:00PM Epigral Limited submits Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulation, 2018

  • Epigral Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    5 Apr 2025, 12:57PM Epigral Limited submits Certificate under Reg. 74(5) of SEBI (DP) Regulations for the quarter ended 31.03.2025.

  • Epigral Ltd - Trading Window

    27 Mar 2025, 12:05PM Epigral Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

  • Epigral Ltd - Trading Window-XBRL

    27 Mar 2025, 12:03PM EPIGRAL LIMITED has informed the Exchange about Closure of Trading Window

  • Epigral Ltd - General Updates

    24 Mar 2025, 1:40PM Epigral Limited has informed about Commissioning of Chlorotoluenes Value Chain Facility.

  • Epigral Ltd - Commissioning Of Chlorotoluenes Value Chain Facility

    24 Mar 2025, 1:43PM Epigral Limited announce the Commissioning of Chlorotoluenes Value Chain Facility.

  • Epigral Ltd - Analysts/Institutional Investor Meet/Con. Call Updates

    22 Mar 2025, 12:30PM Epigral Limited has informed the Exchange about Schedule of meet

  • Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    22 Mar 2025, 12:27PM The management of the Company is having a meeting with \Dhamma Capital\ on 26.03.2025.

  • Epigral Ltd - Analysts/Institutional Investor Meet/Con. Call Updates

    11 Mar 2025, 2:58PM Epigral Limited has informed the Exchange about one-on-one meeting on 12th March, 2025

  • Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    11 Mar 2025, 3:00PM Epigral Limited ('the Company') informs that the Company is having meeting One-on-One meeting on 12th March, 2025

  • Epigral Ltd - Analysts/Institutional Investor Meet/Con. Call Updates

    10 Mar 2025, 10:08AM Epigral Limited has informed the Exchange about the Investors / Analysts visit to the Company s plant at Dahej, Gujarat on 11th March, 2025.

  • Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    10 Mar 2025, 10:11AM Epigral Limited ('the Company') hereby informs about the Investors / Analysts visit to the Company's plant at Dahej, Gujarat on 11th March, 2025.

  • Epigral Ltd - Credit Rating- Revision

    7 Mar 2025, 12:59PM Epigral Limited has informed the Exchange about Review of CRISIL Ratings on the Bank Facilities.

  • Epigral Ltd - Announcement under Regulation 30 (LODR)-Credit Rating

    7 Mar 2025, 12:57PM Review of CRISIL Ratings on the Bank Facilities of Epigral Limited.

  • Epigral Ltd - Analysts/Institutional Investor Meet/Con. Call Updates

    1 Mar 2025, 1:30PM Epigral Limited has informed the Exchange about Schedule of meet

  • Epigral Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    1 Mar 2025, 1:27PM The Management of the Company is having a One on One VC with Kotak Institutional Securities on 05.03.2025.

  • Epigral Ltd - Announcement under Regulation 30 (LODR)-Change in Directorate

    28 Feb 2025, 1:09PM Intimation of change in Directors of the Company.

  • Epigral Ltd - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    28 Feb 2025, 1:06PM EPIGRAL LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

  • Epigral Ltd - Cessation

    28 Feb 2025, 1:05PM Epigral Limited has informed the Exchange regarding Cessation of Mrs NIRALI BHAVIN PARIKH as Non- Executive Independent Director of the company w.e.f.

  • Epigral Ltd - Appointment

    28 Feb 2025, 1:05PM Epigral Limited has informed the Exchange regarding Appointment of Ms PRIYANKA AGARWAL CHOPRA as Non- Executive Independent Director of the company w.

  • Meghmani Finechem commissions captive PowerPlant of 36 MW at Dahej

    30 Sep 2022 , 10:50AM Meghmani Finechem commissions additional 1.06 lakh TPA capacity of caustic soda at Dahej

  • Meghmani Finechem commissions CPVC resin plant in Gujarat

    18 Jul 2022 , 12:12PM Meghmani Finechem commissions India’s largest Chlorinated Polyvinyl Chloride Resin (CPVC Resin) plant
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Epigral Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 2488.11 2216.7777 1945.3109 1715.3315 1099.6362
Liabilities 2488.11 2216.7777 1945.3109 1715.3315 1099.6362
Equity 43.14 41.5502 41.5502 41.5502 41.5527
Gross Profit 710.72 481.2096 688.9974 509.4874 261.3271
Net Profit 356.7 195.7877 353.3575 252.7868 100.839
Cash From Operating Activities 440.56 397.6901 626.1617 283.8167 229.2156
NPM(%) 13.98 10.14 16.14 16.29 12.16
Revenue 2550.13 1929.1916 2188.3997 1550.9414 828.6003
Expenses 1839.41 1447.982 1499.4023 1041.454 567.2732
ROE(%) 25.44 13.96 25.2 18.03 7.19

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
3.5 35 0.32 1779.6
07 Feb 2025 2.5 25 0.32 1788.2
02 Jul 2024 5 50 0.32 1398.9
20 Jun 2023 2.5 25 0.32 990.65
01 Feb 2023 2.5 25 0.32 1143.4

Peers

Other companies within the same industry or sector that are comparable to Epigral Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sharda Cropchem Ltd 631.20 2.44 18.71 17051.67 337.37 1.43
Amines and Plasticizers Ltd 220.88 0.54 29.53 10398.78 361.94 0.23
Grauer and Weil (India) Ltd 115.60 0.00 32.66 42847.43 322.62 0.43
HP Adhesives Ltd 51.09 -1.37 25.67 17364.28 99.28 0.00

Company Info

Our Company was incorporated as "Meghmani Finechem Limited" on September 11, 2007 under the Companies Act, 1956 in the state of Gujarat vide Certificate of Incorporation issued by the Registrar of Companies, Gujarat, Dadra and Nagar Haveli ("RoC"). Our Company obtained Certificate of Commencement of Business on September 17, 2007 issued by RoC.Key Events and Milestones:2007 -Received Certificate of Commencement of Business2008 -International Finance Corporation (World Bank) joined as a partner with 24.97% stake2010 -Started Operation from July 2009 as Greenfield Project of 1,19,000-FY 2010 TPA of Caustic Chlorine and Captive Power Plant of 40MW2015 -Expanded Caustic Chlorine to 1,67,000 TPA with 60MW Captive Power Plant2017 -Commissioned KOH Plant of 21,000 TPA and Convert all Membrane to FY 2017 ZERO Gap2018-Planned for New Caustic Expansion and Chlor-Alkali Derivatives (Chloromethane and Hydrogen Peroxide)-Achieved Turnover of USD 95 Million (? 609 Cr.)2019-Commissioned Chloromethane Plant2020-Commenced the Commercial Operations of Caustic Soda Lye Expansion of 140000 TPA with Captive Power Plant of 36 MW-Announcement for setting up new Epichlorohydrin Plant with 50,000 TPA capacity-Expanded Caustic Chlorine Capacity to 294,000TPA-Expanded capacity of Captive Power Plant to 96MW-Commissioned 60,000 TPA Hydrogen Peroxide Plant 2022 The Company announced the successful commissioning of chlorinated polyvinyl chloride resin (CPVC resin) plant at Dahej in Gujarat. The newly-commissioned facility with a production capacity of 30,000 tonnes per annum (TPA) is the largest of its kind in India. 2023 -Company name has changed to Epigral Ltd. from Meghmani Finechem Ltd.. - 'Commissioning of Wind Solar Hybrid Power Plant'. 2024 -The Company Informed Commissioning of CPVC Compound Plant at its Dahej Facility at Gujarat.

Our Company was incorporated as "Meghmani Finechem Limited" on September 11, 2007 under the Companies Act, 1956 in the state of Gujarat vide Certificate of Incorporation issued by the Registrar of Companies, Gujarat, Dadra and Nagar Haveli ("RoC"). Our Company obtained Certificate of Commencement of Business on September 17, 2007 issued by RoC.Key Events and Milestones:2007 -Received Certificate of Commencement of Business2008 -International Finance Corporation (World Bank) joined as a partner with 24.97% stake2010 -Started Operation from July 2009 as Greenfield Project of 1,19,000-FY 2010 TPA of Caustic Chlorine and Captive Power Plant of 40MW2015 -Expanded Caustic Chlorine to 1,67,000 TPA with 60MW Captive Power Plant2017 -Commissioned KOH Plant of 21,000 TPA and Convert all Membrane to FY 2017 ZERO Gap2018-Planned for New Caustic Expansion and Chlor-Alkali Derivatives (Chloromethane and Hydrogen Peroxide)-Achieved Turnover of USD 95 Million (? 609 Cr.)2019-Commissioned Chloromethane Plant2020-Commenced the Commercial Operations of Caustic Soda Lye Expansion of 140000 TPA with Captive Power Plant of 36 MW-Announcement for setting up new Epichlorohydrin Plant with 50,000 TPA capacity-Expanded Caustic Chlorine Capacity to 294,000TPA-Expanded capacity of Captive Power Plant to 96MW-Commissioned 60,000 TPA Hydrogen Peroxide Plant 2022 The Company announced the successful commissioning of chlorinated polyvinyl chloride resin (CPVC resin) plant at Dahej in Gujarat. The newly-commissioned facility with a production capacity of 30,000 tonnes per annum (TPA) is the largest of its kind in India. 2023 -Company name has changed to Epigral Ltd. from Meghmani Finechem Ltd.. - 'Commissioning of Wind Solar Hybrid Power Plant'. 2024 -The Company Informed Commissioning of CPVC Compound Plant at its Dahej Facility at Gujarat.

Read More

Parent Organisation

Epigral Ltd.

Founded

11/09/2007

Managing Director

Mr.Maulik Jayantibhai Patel

NSE Symbol

EPIGRALEQ

FAQ

The current price of Epigral Ltd is ₹ 1886.00.

The 52-week high for Epigral Ltd is ₹ 1937.70 and the 52-week low is ₹ 1870.10.

The market capitalization of Epigral Ltd is currently ₹ 8136.46. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Epigral Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Epigral Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Epigral Ltd shares.

The CEO of Epigral Ltd is Mr.Maulik Jayantibhai Patel, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT